Exploring challenges in the management and treatment of inclusion body myositis

8Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Purpose of reviewThis review provides an overview of the management and treatment landscape of inclusion body myositis (IBM), while highlighting the current challenges and future directions.Recent findingsIBM is a slowly progressive myopathy that predominantly affects patients over the age of 40, leading to increased morbidity and mortality. Unfortunately, a definitive cure for IBM remains elusive. Various clinical trials targeting inflammatory and some of the noninflammatory pathways have failed. The search for effective disease-modifying treatments faces numerous hurdles including variability in presentation, diagnostic challenges, poor understanding of pathogenesis, scarcity of disease models, a lack of validated outcome measures, and challenges related to clinical trial design. Close monitoring of swallowing and respiratory function, adapting an exercise routine, and addressing mobility issues are the mainstay of management at this time.SummaryAddressing the obstacles encountered by patients with IBM and the medical community presents a multitude of challenges. Effectively surmounting these hurdles requires embracing cutting-edge research strategies aimed at enhancing the management and treatment of IBM, while elevating the quality of life for those affected.

References Powered by Scopus

This article is free to access.

1005Citations
111Readers
Get full text
737Citations
117Readers
Get full text

Cited by Powered by Scopus

4Citations
4Readers
Get full text
1Citations
4Readers

Your institution provides access to this article.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Skolka, M. P., & Naddaf, E. (2023, November 1). Exploring challenges in the management and treatment of inclusion body myositis. Current Opinion in Rheumatology. Lippincott Williams and Wilkins. https://doi.org/10.1097/BOR.0000000000000958

Readers over time

‘23‘2402468

Readers' Seniority

Tooltip

Lecturer / Post doc 1

50%

PhD / Post grad / Masters / Doc 1

50%

Readers' Discipline

Tooltip

Medicine and Dentistry 1

33%

Biochemistry, Genetics and Molecular Bi... 1

33%

Neuroscience 1

33%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free
0